BiOptic Inc.

BioView develops, manufactures and markets innovative automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Operating since 2000, BioView is headquartered in Israel and has a fully owned subsidiary in the Unites States, which is responsible for sales and support in America. BioView’s proprietary imaging, analysis and review technology automatically controls fully motorized fluorescent and bright-field microscopes equipped with high resolution cameras. BioView’s scanning equipment and imaging & analysis algorithms have been tested and validated by world leading institutes, and have been proven to meet the requirements of both research and clinical laboratories. BioView’s DUET imaging and analysis platform has received FDA clearance for several FISH applications for cancer detection and diagnosis and detection of genetic aberrations. Bioview products have CE marking, as well as a Korean, Australian and Thai FDA approval. Products are also an internationally distributed by Abbott Molecular. Founded and managed by experts, BioView leverages its knowledge and extensive expertise in the areas of medical devices combined with clinical and research applications, in creating its breakthrough imaging and analysis solutions.

Genoptic is a progressive Research and Development firm dedicated to further developing and commercialization its already vast and growing Intellectual Property portfolio, based on its nano-optoelectronics breakthroughs. One application for Genoptic technology is within its LED Sign division, where Genoptic gained its first commercial success by competing for and securing some sizable purchase agreements with multiple large national brands; purchase decisions were based on Genoptic’s enhanced features and benefits, resulting from its newly developed technical breakthroughs. Genoptic has compiled an industry-leading Nano-Optoelectronics science team; consisting of in house PhD’s, engineers and scientists. Genoptic has thus far transformed its novel R&D efforts into the commercialization of over 14 novel patent families of various disruptive products and applications, covering multiple industry sectors, globally. Genoptic has recently constructed Canada’s leading state-of-the-art electrical and chemical R&D laboratories, dedicated to Nano-Optoelectronics and Nano-Architectural for scientific research and development. Genoptic is a research and development firm specializing in nano-optoelectronics. We provide a technological advancements in industries such as; Lighting & Display, Solar Energy, Medical Device, Indoor Agriculture, and for the Internet of Things (IoT). Genoptic, utilizing advanced nano-technologies, has integrated its advanced Smart IC Power Chip solution to combine; power circuitry, RF communication, and control system into a single integrated circuit microchip.

Photonic BioSystems provides market-disruptive sensing solutions for protecting the human health, water/food supply, and environment of the world. With over 25 years of award-winning research, Photonic BioSystems specializes in the development of liquid handling techniques, opto-electronic instruments, and bioassay systems. The innovative biotech company also develops technologies for ultra-sensitive and rapid detection of oxygen and ammonia.

OPS Diagnostics was established in 2001 as an outlet for products developed by BT&C, Inc. Consequently, we are able to offer our clients these products with the added value of excellent technical support. Products sold by OPS Diagnostics have been tested, designed, and/or evaluated by our scientists thus guaranteeing that the product meets the need of our customers. We work in conjunction with other scientific supply and manufacturing companies to provide practical solutions to common needs of scientists. We routinely help our clients' to apply these products in new and unique manners to overcome research barriers. We also help in the design of custom products. Burden founded Biotechnology Training & Consulting (BT&C) in 1987 in response to the demand for technical support and training in the biotechnology/pharmaceutical industry. OPS Diagnostics products are for laboratory use only.

On-chip Biotechnologies, incorporated in 2005, is the first company in the world to launch a microfluidic chip-based cell sorter on the market. Our microfluidic chip-based cell sorter, On-chip Sort, designed and manufactured in Japan, uses a disposable microfluidic chip as the core of its technology. Our microfluidic chips are manufactured with Japan’s outstanding high-precision plastic injection molding technology. Therefore, as a prevention for post-sorting cell changes with conventional cell sorter, we developed On-chip Sort. On-chip Biotechnologies is the first company in the world to launch a microfluidic chip-based cell sorter on the market.Our microfluidic chip-based cell sorter, On-chip Sort, designed and manufactured in Japan, uses a disposable microfluidic chip as the core of its technology.Our mission is to assist researchers in accelerating the world’s new discoveries in life science, drug development and diagnostics with On-chip Sort. On-chip products delivered in University of Birmingham on February 13. The use of the disposable microfluidic chip as the core of On-chip Sort realizes great benefits over conventional cell sorters. On-chip Biotechnologies currently offer two instruments: On-chip Sort (cell sorter) and On-chip SPiS (single cell dispenser).

Our products have evolved from the integration of several companies including: Artek Systems Corporation with ultrasonic homogenizers (sonic dismembrators) and video based automated colony counters used to count bacterial colonies on petri dishes; Bausch and Lomb OMNICON Vision Systems with "turn key" biomedical image analysis applications; and Dynatech's Imaging Products Group and its successor; Imaging Products International, Inc. With over 30 years of experience, BioLogics has manufactured laboratory and medical instrumentation for the clinical, research, chemical, environmental, industrial and pharmaceutical laboratories throughout the world. BioLogics was founded in 1996 with a commitment to improve Life Science instrumentation. BioLogics have always been committed to providing our customers with unsurpassed value and reliable products at the fairest price. With our extensive market experience, strong customer networks, and automation expertise, we developed modular, scalable systems that automate sample storage, management, and processing. NEW FOR BIOLOGICS BioLogics manufactures the OMNICON Antibiotic Potency Testing systems and Ultrasonic Homogenizers. Sonifier is a registered trademark of Branson Ultrasonics Corporation. BioLogics, a USA manufacturer and leading innovator of laboratory instrumentation for the Life Sciences.